TLP Group’s Boston Scientific BSX Stock Holding History

TLP Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-960	Closed	-$24K	–	410
2017 Q4	$24K	Buy	960 +902	+1,555%	+$24.9K	0.02%	224
2017 Q3	$2K	Buy	+58	New	+$1.6K	﹤0.01%	492

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

TLP Group's BSX Position: Q1 2018 in Review

TLP Group sold out of Boston Scientific (BSX) in Q1 2018, closing a stake of 960 shares — an estimated $24K sold.

TLP Group first reported a position in BSX in Q3 2017 and held it in 2 quarters. The position peaked at $24K in Q4 2017. 633 funds tracked by Wall St. Rank hold BSX as of Q1 2018.

TLP Group reported no remaining Boston Scientific position as of Q1 2018 after selling out during the quarter.
TLP Group sold 960 Boston Scientific shares in Q1 2018, an estimated $24K.
TLP Group first reported a position in Boston Scientific in Q3 2017 and held it in 2 quarters.
TLP Group's Boston Scientific position peaked at $24K in Q4 2017.
633 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2018.

Based on TLP Group's 13F filing for Q1 2018, filed 16 May 2018.